Terms ending in 2037
Every in-force patent on Alector LLC's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,849,992 | Methods of Screening for Sortilin Binding Antagonists In force · High confidence | Alector LLC | In force | High confidence | |
| US 12,186,409 | Methods of Screening for Sortilin Binding Antagonists In force · High confidence | Alector LLC | In force | High confidence | |
| US 10,875,919 | Chimeric Receptors and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 11,472,877 | Anti-TREM1 Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence | |
| US 12,226,482 | Anti-SIRP-Alpha Antibodies and Methods of Use Thereof In force · High confidence | Alector LLC | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.